About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04158193

Acupuncture for Breast Cancer Related Lymphedema

The purpose of this study is to evaluate the clinical efficacy of acupuncture on chronic upper limb lymphedema in patients with breast cancer surgery

Lead sponsor: Tianjin University of Traditional Chinese Medicine•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Pan XingFang

CONTACT

18649067519 [email protected]

Pan XingFang, Study Principal Investigator

CONTACT

18649067519 [email protected]

Sponsors

Lead Sponsor

Tianjin University of Traditional Chinese Medicine

Collaborators

Baokang Hospital Affiliated to Tianjin University of Traditional Chinese Medicine
Tianjin Medical University Cancer Institute and Hospital
Gansu Provincial Cancer Hospital
The Second Affiliated Hospital of Baotou Medical College

Age

18 - 80 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•At least 6 months after breast cancer surgery and presents with persistent breast cancer related upper extremity lymphedema for at least 3 months.
•Stage II lymphedema according to the 2016 consensus by the international society of lymphology.
•Women aged 18 to 80 years
•Out-patients
•Estimated life expectancy \> 6 months
•Upper extremity lymphedema is defined a more than 10% volume difference between the affected and unaffected arms

Exclusion Criteria

•Bilateral breast cancer related lymphedema
•Tumor metastasis or recurrent patient
•Patients who is undergoing chemotherapy, radiation therapy or targeted therapy
•Taking diuretic
•Upper extremity lymphedema reached more than 80% volume difference between the affected and unaffected arms
•History of primary lymphedema
•A diagnosis of severe heart, liver, kidney or hematologic disease
•Edema caused by upper extremity disability or other conditions such as heart failure, kidney disease or malnutrition
•Have hypoproteinemia
•Inflammation, scar, or trauma at the site of operation, or other active skin infections
•Unable to self-care, had a history of psychological disorders, or unable to communicate
•Received lymphedema treatment within the past 1 month
•Pregnancy or breastfeeding
•The presence of electronic medical device implants
•Deny to sign the informed written consent, or unwilling to conform to randomization
•Participation in other clinical trials during the study period

Related studies

LLLT for BCRL: a Randomized, Placebo-controlled Study

NCT05725265 · Breast Cancer Lymphedema

Active Not RecruitingPhase 3

Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

NCT04241341 · Breast Cancer Lymphedema

Active Not Recruiting

Effect of the Axillary Lymphatic /Vein Reflux Ratio on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer

NCT05246592 · Breast Cancer Lymphedema

Effectiveness of CDT for the Treatment of Lymphedema in Breast Cancer Patients Who Received LVA Surgery

NCT06569719 · Breast Cancer Lymphedema

The Effect of Arm Exercises on Arm Oedema After Breast Cancer Surgery

NCT05303675 · Breast Cancer Female, Breast Cancer Lymphedema

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2019Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment60

Start dateNov 2019

Last updatedNov 8, 2019

Condition

Breast Cancer Lymphedema

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions